Inventor · disambiguated record
Dan Smith
Also filed as: SMITH DAN · SMITH DAN J · SMITH DAN JOSEPH
2 granted patents·13 pending applications·7 citations·filing 2000–2022
53Inventor score
Top patents by PatentIndex Score
15 records- 0173US7141236B2Methods and compositions for delivering macromolecules to or via the respiratory tractNEKTAR THERAPEUTICS·Filed 2002·Granted Nov 28, 2006·5 cites·39 claims
- 0270US8809290B2Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cellsBOT ADRIAN·Filed 2011·Granted Aug 19, 2014·2 cites·13 claims
- 0363US2007065369A1Novel methods and composition for delivering macromolecules to or via the respiratory tractBOT ADRIAN I·Filed 2006·Application pending·0 cites
- 0457US2009169571A1Selected ma motifs to include cell death and/or apoptosisMULTICELL IMMUNOTHERAPEUTICS I·Filed 2008·Application pending·0 cites
- 0554US2007037769A1Compositions and methods to treat and control tumors by loading antigen presenting cellsMULTICELL IMMUNOTHERAPEUTICS I·Filed 2006·Application pending·0 cites
- 0653US2024189446A1Compositions and methods for delivery of nucleic acidsPOSEIDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0752US2005074449A1Novel methods and compositions to upregulate, redirect or limit immune responses to peptides, proteins and other bioactive compounds and vectors expressing the sameFiled 2004·Application pending·0 cites
- 0852US2002106368A1Novel methods and compositions to upregulate, redirect or limit immune responses to peptides, proteins and other bioactive compounds and vectors expressing the sameFiled 2001·Application pending·0 cites
- 0951US2021260058A1Nilotinib Compositions with Enhanced SolubilityNEOFORM BIOPHARMACEUTICAL LTD·Filed 2021·Application pending·0 cites
- 1048US2006193855A1Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cellsBOT ADRIAN·Filed 2003·Application pending·0 cites
- 1146US2005222060A1Compositions and methods to initiate or enhance antibody and major-histocompatibility class I or class II-restricted t cell responses by using immunomodulatory, non-coding rna motifsBOT ADRIAN L·Filed 2003·Application pending·0 cites
- 1244US2002103165A1Engineered spray-dried lipid-based microparticles for cellular targetingALLIANCE PHARMA·Filed 2000·Application pending·0 cites
- 1344US2006172959A1Selected rna motifs to include cell death and/or apoptosisSMITH DAN·Filed 2004·Application pending·0 cites
- 1442US2012189645A1Compositions and methods to treat and control tumorsBOT ADRIAN·Filed 2010·Application pending·0 cites
- 1523US2015219636A1Isolation of cells and biological substances using buoyant microbubblesTARGESON INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dan Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →